Cancer-associated Thrombosis
8 clinical trials · Condition
◉ Watch Cancer-associated Thrombosis
| Record | Firm | Date |
|---|---|---|
| API-CAT STUDY for APIxaban Cancer Associated Thrombosis (NCT03692065) | Assistance Publique - Hôpitaux de Paris | 2018-10-11 |
| A Randomized Phase II Open Label Study to Compare the Safety and Efficacy of Subcutaneous Dalteparin Versus Direct Oral Anticoagulants for Cancer-associated Venous Thromboembolism (NCT03139487) | Asan Medical Center | 2017-08-07 |
| Rivaroxaban for the Prevention of Venous Thromboembolism in Asian Patients With Cancer (NCT01989845) | Seoul National University Hospital | 2013-10-01 |
| A New Clinic-Genetic Risk Score for Predicting Venous Thromboembolic Events in Cancer Patient (NCT03114618) | Andres muñoz | 2013-03-01 |
| Efficacy and Safety of Extended Anticoagulant Therapy in Cancer Associated Thrombosis in Thai Population (NCT07388056) | Thammasat University | 2012-01-01 |
Track Cancer-associated Thrombosis automatically
Every clearance here is in the API, with alerts when new ones post.